Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Research indicates that 64% of patients find their ideal maintenance dose within this range
It is designed to activate both GIP and GLP-1 receptors with specific binding affinities: GIP receptor affinity comparable to native GIP, and GLP-1 receptor affinity approximately 5-fold weaker than native GLP-1, resulting in an imbalanced agonist profile that favors GIP receptor activation
Because GLP-1 medications require regular subcutaneous injection, reliable and patient-friendly delivery systems are critical for successful therapy adoption
Glucagon receptor: The new addition
A separate class of GH secretagogues (for example the ghrelin-mimetic compounds that act on the growth-hormone-secretagogue receptor) works through a different receptor entirely and is sometimes studied in combination with GHRH analogs in research settings
US$ 21.98
US$ 28.51
US$ 23.86
US$ 27.09
US$ 25.13
